Drugs News and Research

RSS

Immune-promoting drugs may control recurrent disease

Nearly half of the 700,000 cancer patients who undergo surgical removal of a primary tumor each year suffer a recurrence of their disease at some point, and many of those patients will eventually die from their disease.

28 Dec 2012

Genome sequencing may help identify new targets to treat Pneumocystis pneumonia

Scientists have sequenced the genome of the fungus Pneumocystis jirovecii, an advancement that could help identify new targets for drugs to treat and prevent Pneumocystis pneumonia, a common and often deadly infection in immunocompromised patients.

26 Dec 2012

Blood transfusion for patients with myocardial infarction associated with increased all-cause mortality

A meta-analysis of 10 studies suggests that receipt of a blood transfusion among patients with myocardial infarction (heart attack) was associated with increased all-cause mortality compared with not receiving a blood transfusion during heart attack, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication.

25 Dec 2012

Study suggests genetic component in pain response among children

At least two common gene variants are linked to "clinically meaningful" differences in pain scores in children after major surgery, reports a study in the January issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

25 Dec 2012

Elevated C-reactive protein linked to psychological distress and depression

Elevated levels of C-reactive protein, a marker of inflammatory disease, appear to be associated with increased risk of psychological distress and depression in the general population of adults in Denmark, according to a report published Online First by Archives of General Psychiatry, a JAMA Network publication.

25 Dec 2012

TNF inhibitor efficacy may depend on brain activity

How well a patient responds to tumor necrosis factor inhibitor therapy may depend on brain activity reflecting the individual’s perception of their rheumatoid arthritis, scientists believe.

24 Dec 2012

Antibody type prognostic for myasthenia gravis patients

Patients who have myasthenia gravis are more likely to have a severe form of the disease and more difficulty achieving remission if they are seropositive for antibodies to muscle-specific kinase, report researchers.

24 Dec 2012

Third of high school seniors take marijuana

High levels of use of marijuana among US teens continue unabated, show the 2012 results of the National Institute on Drug Abuse’s ‘Monitoring the Future’ survey.

22 Dec 2012

High-dose rifampicin combination could improve meningitis survival

A treatment regimen including high-dose rifampicin administered intravenously in addition to standard or high-dose moxifloxacin has an acceptable safety profile and could improve survival for patients with tuberculous meningitis, indicate phase II trial results.

22 Dec 2012

New insight into structure of Cathepsin B protein

Using the world's most powerful X-ray free-electron laser, an international team of researchers, including scientists of the Max Planck Institute for Medical Research in Heidelberg, has obtained new insight into the structure of a medicinally important protein that may serve as a blueprint for the development of drugs to fight sleeping sickness. Science magazine have chosen the experimental study as one of the top ten scientific breakthroughs of the year.

21 Dec 2012

As clock runs down, 'fiscal cliff' negotiations stall

Speaker John Boehner pledged to bring his alternative option to a House vote as early as today. Meanwhile, the issue of savings in the Medicare program continue to be examined.

21 Dec 2012

Acorda Therapeutics acquires Neuronex

Acorda Therapeutics, Inc. today announced that the Company has completed the acquisition of Neuronex, Inc., a privately held company developing a nasal spray formulation of diazepam. Under the terms of the agreement, Acorda paid $6.8 million to Neuronex to complete the acquisition.

21 Dec 2012

New low-cost combined therapy shows promise against malaria

Malaria brings misery and death to millions in the developing world each year, and fighting it keeps medical researchers up at night because the mosquito-borne parasite Plasmodium falciparum, which causes the deadliest form of the disease, has developed resistance to every drug thrown at it. Resistance has cut short the useful life of nearly every therapy tried so far, experts say.

21 Dec 2012

UAB research succeeds in testing a vaccine against leishmaniasis

A research coordinated by the UAB has succeeded in testing a vaccine against leishmaniasis. The vaccine was tested with the best animal model existing, the golden hamster, and can be produced at low costs by using insect larvae.

21 Dec 2012

U.S. 'unprepared for' resurgence of MDR-TB, Wall Street Journal reports

"Multidrug-resistant tuberculosis (TB) is at epidemic proportions in some parts of the world -- a growing problem the U.S. is surprisingly unprepared for," the Wall Street Journal reports.

21 Dec 2012

Researcher looks at role of TIMP3 protein linked with aortic aneurysms in the abdomen

A researcher with the Faculty of Medicine & Dentistry and the Mazankowski Alberta Heart Institute is looking closely at a molecule linked to aortic aneurysms in the abdomen, and her findings could lead to a treatment to reduce swelling of the aortic artery, which would be a life-saving treatment.

21 Dec 2012

FDA seeks input from states on drug compounders

FDA Commissioner Margaret Hamburg convened a meeting that included federal officials and representatives from state boards of pharmacy and governors' offices. Meanwhile, the Los Angeles Times reports on "rogue pharmacists."

21 Dec 2012

NPR, Inter Press Service examine efforts to prevent drug-resistant malaria

As part of its continuing coverage of malaria, NPR's "Shots" blog features a story on counterfeit anti-malarial drugs, which "are among the most popular drugs to fake." According to the blog, "These faux pharmaceuticals are particularly dangerous because malaria can kill a person in a matter of days," and, if the drugs contain only a small amount of the real drug, they can contribute to the development of drug-resistant malaria parasites.

21 Dec 2012

New MRI scans accurately measure damage to blood-brain barrier in stroke victims

Johns Hopkins researchers have developed a new way of looking at standard MRI scans that more accurately measures damage to the blood-brain barrier in stroke victims, a process they hope will lead to safer, more individualized treatment of blood clots in the brain and better outcomes.

21 Dec 2012

Addiction specialists co-edit new textbook to help Canadians stop smoking

Researchers from the University of Alberta are helping Canadian smokers butt out with a new textbook designed to give health professionals the right tools to treat tobacco addiction.

21 Dec 2012